Overview

Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection

Status:
Completed

Trial end date:
2016-01-01

Target enrollment:

Participant gender:

Summary

This study will look at the safety and efficacy of 8 week and 12 week treatment with Sofosbuvir and Simeprevir in treatment-naïve and treatment-experienced patients with chronic hepatitis C genotype 4.

Phase:

Phase 2

Details

Lead Sponsor:

Peter J. Ruane, M.D.

Collaborator:

Janssen Scientific Affairs, LLC

Treatments:

Simeprevir
Sofosbuvir